No CrossRef data available.
DNA Diagnosis in Oncology
Published online by Cambridge University Press: 10 March 2009
Abstract
Our understanding of the genetic changes that transform normal cells into malignant cells is increasing at a remarkable pace. Some of the changes involve detectable cytogenetic aberrations, whereas others are identifiable only at the molecular level. Many of the structural cytogenetic changes have also been defined molecularly because the genes involved have been cloned. Thus, we are approaching the stage in which the DNA obtained from tumor tissue can be analyzed to detect the presence of a series of chromosomal and molecular alterations. These studies provide important information regarding the precise diagnosis of the tumor type as well as prognostic information about the likely response to therapy and survival.
- Type
- Special Section: Genetic Technology
- Information
- International Journal of Technology Assessment in Health Care , Volume 10 , Issue 4 , Fall 1994 , pp. 644 - 654
- Copyright
- Copyright © Cambridge University Press 1994
References
REFERENCES
1.Aaronson, S. A.Growth factors and cancer. Science, 1991, 254, 1146–53.CrossRefGoogle ScholarPubMed
2.Advances in understanding genetic changes in cancer: Impact on diagnosis and treatment decisions in the 1990s. Washington DC: National Academy Press, 1992.Google Scholar
3.Fletcher, J. A.Kozakewich, H. P.Hoffer, F. A. et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. New England Journal of Medicine, 1991, 324, 436–42.CrossRefGoogle ScholarPubMed
4.Heim, S. & Mitelman, F.Primary chromosome abnormalities in human neoplasia. Advances in Cancer Research, 1989, 52, 1–43.CrossRefGoogle ScholarPubMed
5.Kinzler, K. W.Nilbert, M. C.Su, L.-K. et al. Identification of FAP locus genes from chromosome 5q21. Science, 1991, 253, 661–65.CrossRefGoogle ScholarPubMed
6.Malkin, D.Li, F. P.Strong, L. C. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 1990, 250, 1233–38.CrossRefGoogle Scholar
7.Mitelman, F.Catalog of chromosome aberrations in cancer. New York, NY: Wiley- Liss, 1991.Google Scholar
8.Nucifora, G.Birn, D. J.Ericksnon, P. et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) AML. Blood, 1993, 81, 883–88.CrossRefGoogle Scholar
9.Pinkel, D., Landegent, J., Collins, C. et al. , Fluorescent in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4. Proceedings of the National Academy of Sciences of the United States of America, 1988, 87, 9138–42.CrossRefGoogle Scholar
10.Rowley, J. D.Recurring chromosomal abnormalities in leukemia and lymphoma. Seminars in Hematology, 1990, 27, 122–36.Google ScholarPubMed
11.Sandberg, A. A.The chromosomes in human cancer and leukemia. Amsterdam, the Netherlands: Elsevier, 1990.Google Scholar
12.Seeger, R. C., Brodeur, G. M., Sather, H. et al. , Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. New England Journal of Medicine, 1985, 313, 1111–16.CrossRefGoogle ScholarPubMed
13.Sklar, J., & Weiss, S. L. M. Application of antigen receptor gene rearrangement to the diagnosis and characterization of lymphoid neoplasms. Annual Review of Medicine, 1988, 315–34.CrossRefGoogle Scholar
14.Slamon, D. J., Godolphin, W., Jones, L. A. et al. , Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 1989, 244, 707–12.CrossRefGoogle ScholarPubMed
15.Solomon, E., Borrow, J., & Goddard, A. D.Chromosome aberrations and cancer. Science, 1991, 254, 1153–60.CrossRefGoogle ScholarPubMed